Alain Cohen‐Solal

Also affiliated with Université Paris Cité, Sorbonne Paris Cité, Assistance Publique – Hôpitaux de Paris, Hôpital Fernand-Widal, Hôpital Lariboisière, Paris Cardiovascular Research Center, Marqueurs cardiovasculaires en situation de stress

Medicine

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 3 papers. Top paper: “Effect of Omecamtiv Mecarbil on Exercise Capacity in Chronic Heart Failure With Reduced Ejection Fraction”.

Effect of Omecamtiv Mecarbil on Exercise Capacity in Chronic Heart Failure With Reduced Ejection Fraction

JAMA(2022)10.1001/jama.2022.11016

N/A

1.4DataRank · unranked

62 citations

Adriaan A. Voors, Alain Cohen‐Solal, Marco Metra, David J. Whellan, Justin A. Ezekowitz +12 more

Vericiguat for patients with heart failure and reduced ejection fraction across the risk spectrum: an individual participant data analysis of the VICTORIA and VICTOR trials

The Lancet(2025)10.1016/s0140-6736(25)01682-4

N/A

0.550DataRank · unranked

38 citations

Christopher M. O’Connor, Javed Butler, Ciaran J. McMullan, Kevin J. Anstrom, Irina Barash +84 more

Regional variation of effects of new antidiabetic medications in cardiovascular outcome trials

American Heart Journal(2021)10.1016/j.ahj.2021.06.001

N/A

0DataRank · unranked

2 citations

Beth A. Davison, Christopher Edwards, Stefanie Senger, John R. Teerlink, Faı̈ez Zannad +10 more